Company intelligence / Profile preview
Acella Pharmaceuticals
Alpharetta, Georgia, United Statesacellapharma.com ↗
- Ownership
- Private
- Employees
- ~82
- Development stage
- Other
01
Overview
Acella Pharmaceuticals markets a broad portfolio of affordable generic and specialty pharmaceutical products in the U.S., with commercialized therapies for hypothyroidism and myasthenia gravis among others. The company focuses on quality generics and value-added formulations across multiple therapeutic areas.
- Therapeutic areas
- NeurologyMetabolic DisordersPulmonologyInfectious DiseasesDermatologyHematologyEndocrinologyGastroenterologyRheumatologyWomen's Health
- Modalities
- Small moleculeHormoneProtein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Milla Pharmaceuticals/A.forall for commercialization of pyridostigmine bromide syrup ANDA approval in U.S.Paloma Health partnership focused on hypothyroidism patient support/services
Beyond the preview
Go deeper on Acella Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acella Pharmaceuticals.